Physician

Ophthalmology

Dr. Gary A. Pomeranz, MD


Doctor Gary A. Pomeranz, MD is an expert in the field of Ophthalmology. He researched medicine at University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is a one of the best medicals schools. University of Colorado Denver School of Medicine is ranked 35 in research and 8 in primary care medicine He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Gary A. Pomeranz, MD is a published doctor and has 1 publication published. The lastest was: 'Multifocal choroidal melanoma in ocular melanocytosis.' Gary Pomeranz is registered with Medicare and accepts Medicare payments.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1508974015
NPPES Provider LastName   POMERANZ
NPPES Provider FirstName   GARY
NPPES Provider ZIPCode   895214808
NPPES Provider State   NV
Specialty Description   Ophthalmology
Total Claim Count   608.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1508974015
Last Name Of The Provider POMERANZ
First Name Of The Provider GARY
View All

Similar Doctors


Dr. Thomas R. Conklin, MD
This Doctor is OpenDoctor Recommended.
Dr. Steve H. Chang, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Gregory L. Cohen, MD
This Doctor is OpenDoctor Recommended.
Dr. William Durant, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. David B. Chaffin, MD
This Doctor is OpenDoctor Recommended.
Dr. Hardeep S. Dhindsa, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Cynthia A. Ferreira, MD
This Doctor is OpenDoctor Recommended.
Dr. Patrick M. Hsueh, MD
This Doctor is OpenDoctor Recommended.
Dr. Matthew B. Mills, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog